The patient had a CAT scan in [**4-/2170**], which showed interval progression of intrathoracic metastatic disease.
The patient had approximately 200 to 250 cc of blood loss.
Status post IL2 therapy and PIK 787.
The patient also on [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1819**] clinical trial.
Serial hematocrits were checked.
The patient's initial hematocrit was 33; this dropped to 29, but then prior to admission had rose to 29.7.
